Metallo-β-lactamase mediated rapid increase in carbapenem resistance of

Hasnain Anjum,Shomaia Yasmin Mitu,Md. Shamsul Arefin,Meftahul Jannat Mitu,Md. Sabir Hossain,Salequl Islam,M.A. Karim Rumi,M. Hasibur Rahman
DOI: https://doi.org/10.1101/2024.03.21.24304089
2024-03-28
Abstract:Antibiotic-resistant is a common nosocomial pathogen all over the world. We detected the presence of in 22% (53 out of 238) of the test samples collected from patients with infections including secondary wound infections, abscesses and urinary tract infections admitted to two academic hospitals in Bangladesh. Resistance to carbapenems (imipenem, and meropenem) was present among 30% (16 out of 53) of these clinical isolates, which is more than 2-fold higher compared to that of previous studies. Such a rapid increase in carbapenem resistance was mediated by metallo-β-lactamase (MBL). Expression of MBL was detected in 90% (14 out of 16) of these resistant isolates. Molecular analyses revealed that the carbapenem-resistant isolates carried at least one of the MBL variants, either VIM or -NDM-1. All the NDM-1 positives carried a 0.5 MDa plasmid. ERIC-PCR revealed the highly heterogeneous nature of the isolates indicating multiple sources of infection within the hospital. However, the majority of XDR isolates belonged to a single cluster of drug-resistant bacterial infections. These findings indicate that Metallo-β-lactamase (MBL) mediated resistance to carbapenem in poses a serious threat to the spread of infections among hospitalized patients.
Public and Global Health
What problem does this paper attempt to address?